Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...